Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares saw a handy gain on Thursday after the U.S. Food and Drug Administration (FDA) gave the...
ELITechGroup Biomedical Systems, World Leader for Laboratory Diagnosis of Cystic Fibrosis, Launches
LOGAN, Utah--(BUSINESS WIRE)--Aug 16, 2018--ELITechGroup Biomedical Systems (EBS), known for worldwide transformation and innovation of...
IRT Test
Cystic fibrosis is caused by mutations in the CFTR gene, which results in thick mucus building up around organs and tissues. This is...
Orkambi Not Seen to Significantly Improve Blood Glucose Levels in CF Patients in Small Study
Analysis of blood glucose levels in cystic fibrosis (CF) patients being treated with Orkambi (ivacaftor/lumacaftor) shows that the...
New Lung Cell Type Linked to Cystic Fibrosis Emerges From Mouse, Human Cell Atlas Studies
NEW YORK (GenomeWeb) – Two new studies that used single-cell RNA sequencing to profile tracheal or bronchial tissue from mice or humans...
Cystic Fibrosis Further Explained by Rare Cell Type Discovery
Investigators from the Broad Institute of MIT and Harvard and Massachusetts General Hospital (MGH) have discovered a rare cell type in...